(PTI) Max Healthcare announced its financial results for the three months ended September 30, 2022, today.
The network gross revenue stood at ₹1,567 Cr during the second quarter reflecting a growth of 17% YoY and 6% QoQ on a like-to-like basis2. The network operating EBITDA stood at ₹410 Cr compared to ₹362 Cr in the corresponding quarter last year (Q2 FY22) and ₹370 Cr in the previous quarter (Q1 FY23).
This reflects a growth of 22% YoY and 11% QoQ on a like-to-like basis2. Correspondingly, the Operating EBITDA margin stood at 27.7% for the quarter, compared to 26.7% in Q2 FY22 and 26.6% in Q1 FY23. EBITDA per bed2 during the quarter improved to INR 64 lakhs, registering a growth of 17% YoY and 4% QoQ.
Abhay Soi, Chairman and MD, Max Healthcare Institute Ltd, said: "The performance for Q2 FY23 is as per our expectations and reflects the focus on execution across the organisation in line with our articulated strategy. Healthcare sector in general and Max Healthcare in particular are making significant investments over the next 4-5 years leading to huge employment opportunities and a multiplier effect on GDP."
He added that the impetus provided by the government through its focus on healthcare and 'heal in India' initiatives will provide a watershed moment for the industry.